SINGAPORE INST OF ADV MED: Secures SGX-ST Approval to Issue Up to Approximately 493 Million Rights Shares and Free Warrants

NewTimeSpace News: On 12 May 2026, SINGAPORE INST OF ADV MED announced that the Company obtained the listing and quotation approval from SGX Catalist on 11 May for its previously disclosed non-underwritten renounceable rights issue together with free warrants.

Under the arrangement, the Company will issue up to approximately 493 million rights shares at an issue price of S$0.031 per share, on the entitlement basis of two rights shares for every five existing shares held. One free warrant will be attached to each rights share subscribed, with a maximum of around 493 million warrants to be issued in total. Each warrant entitles the holder to subscribe for one new share at an exercise price of S$0.050. Upon full exercise of the warrants, up to an additional 493 million new shares may be issued.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.